Company
Ollin Biosciences
Accelerating Next Generation Therapies for Ophthalmology
Also known as Ollin Biosciences, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2023
- Legal name
- Ollin Biosciences, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Established in 2023, Ollin BiosciencesTM is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what’s possible in ophthalmology.
Funding snapshot
- Total raised
- $156MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $156M2026-05-14
Funding rounds
- Round, 2026
- $156M2026-05-14, SEC form D sold, 32 investors
Products
- Other
- OLN102
- Other
- OLN324
Loading relationship preview